Clinical Trial Update: Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of Racotumomab in pediatric tumors expressing N-glycolylated gangliosides has completed enrollment and reported results for neuroblasto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Glioma
• Neuroblastoma
• Retinoblastoma
• Wilms Tumor

Drugs mentioned

• Racotumomab (racotumomab)

Snippet

Sponsor: Laboratorio Elea Phoenix S.A. | Conditions: Neuroblastoma, Ewing's Sarcoma | Phase 1 | Status: COMPLETED